Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Dorfinger

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Wiener Klinische Wochenschrift|December 23, 2016
Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)Klaus Eredics, Karl Dorfinger, Gero Kramer, et al.
Wiener Klinische Wochenschrift|February 3, 2016
Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancerAnton Ponholzer, Wolfgang Loidl, Jasmin Bektic, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Wiener Klinische Wochenschrift|December 23, 2016
Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)Klaus Eredics, Karl Dorfinger, Gero Kramer, et al.
Wiener Klinische Wochenschrift|February 3, 2016
Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancerAnton Ponholzer, Wolfgang Loidl, Jasmin Bektic, et al.
Pageof 1